Ejaculatory and Orgasmic Dysfunction Following Prostate Cancer Therapy: Clinical Management
| Autor: | Jose Saavedra-Belaunde, Travis P. Green, Run Wang |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
media_common.quotation_subject 030232 urology & nephrology MEDLINE Review Orgasm anejaculation 03 medical and health sciences Prostate cancer 0302 clinical medicine Premature ejaculation orgasm medicine Intensive care medicine Reproductive health media_common 030219 obstetrics & reproductive medicine business.industry climacturia prostate cancer medicine.disease premature ejaculation ejaculatory dysfunction painful ejaculation Erectile dysfunction Orgasmic dysfunction medicine.symptom business dysorgasmia Anejaculation |
| Zdroj: | Medical Sciences |
| ISSN: | 2076-3271 |
| DOI: | 10.3390/medsci7120109 |
| Popis: | The majority of sexual health research has focused on erectile dysfunction following prostate cancer treatment. Ejaculatory and orgasmic dysfunction are significant side effects following the treatment of prostate cancer. Orgasmic dysfunction covers a range of issues including premature ejaculation, anorgasmia, dysorgasmia, and climacturia. This review provides an overview of prevalence and management options to deal with orgasmic dysfunction. A Medline Pubmed search was used to identify articles relating to these problems. We found that orgasmic dysfunction has a very large impact on patients’ lives following prostate cancer treatment and there are ways for physicians to treat it. Management of patients’ sexual health should be focused not only on erectile dysfunction, but on orgasmic dysfunction as well in order to ensure a healthy sexual life for patients and their partners. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|